Tapentadol is partly metabolized through the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medicine that enhance or repress the activity/expression of one or more of such enzymes, in addition to with substrates of these enzymes (on account of Opposition for the enzyme); some enzyme mediators/substrates https://thomase676jbt8.madmouseblog.com/profile